Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
Lab-testing giant ALS has surfed a boom in minerals testing to produce a strong interim result, despite a drug assay downturn. This was achieved despite “ongoing geopolitical and macro uncertainty".
A new wave of expressive, humanlike AI is helping people who cannot speak reclaim presence, connection, and dignity in ...
Testing giant ALS has shrugged off weak drug testing revenues to post a 12% half-year profit boost, so it’s no ‘pharmageddon’ Tryptamine’s binge eating psychedelics trial kicks up a gear Impedimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback